Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
주식 순위 #16725
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
주가
$3.78
마지막 동기화: 2026-03-17
시가총액
$276.54M
변동 (1일)
0.00%
변동 (1년)
45.53%
국가
CA
거래 NervGen Pharma Corp. (NGEN)

카테고리

NervGen Pharma Corp. (NGEN)의 주가 이력
최고 종가: $3.98 (2026-03-01 기준)

최저 종가: $1.12 (2019-03-01 기준)
NervGen Pharma Corp.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.21 -10.03%
AU
$755.10 7.83%
CH